A FTSE 100 dividend growth stock I’d buy and hold all the way through to 2030

Royston Wild pores over an exceptional FTSE 100 (INDEXFTSE: UKX) dividend stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Two hands holding champagne glasses toasting each other with Paris in the background

Image source: Getty Images.

As a holder of several FTSE 100 stocks myself, I have to admit that I’m far from concerned by the share market sell-off that has continued into another week.

Share market investment has been proven time and again to be one of the most effective ways of putting your money to work over the long-term. And I have no intention of selling any of my blue-chip holdings for at least another decade.

A Footsie company that I haven’t bought into just yet is NMC Health (LSE: NMC). But given the strong probability that it should continue to thrive through the 2020s and beyond, I am seriously tempted to splash the cash on this healthcare star.

Forecasts bumped higher

Last time I covered NMC I mentioned the exceptional revenues possibilities created by its buzzing expansion drive across the United Arab Emirates, a strategy which is supplemented by clever acquisition action. And just this week the fruits of its programme were once again laid bare.

The firm said that it was revising up its forecasts for 2018 following a strong second half, and it now anticipates that revenues will rise 24% year-on-year, up 20 basis points from its prior projections. Consequently the hospital operator hiked its EBITDA guidance too, to $480m from $465m previously.

And this strong performance is expected to continue into next year, NMC predicting revenues rises of between 22% and 24% and EBITDA improvement in the range of 18% to 20%. The firm said that “2019 guidance will also point towards continuation of strong organic growth on the back of sustained ramp-up at key facilities, integration and expansion of acquired entities as well as strong operational performance.”

With the company pledging to continue opening new greenfield facilities and expanding its existing infrastructure next year too, there’s little reason to expect profits growth in the lucrative markets of the Middle East from continuing to charge beyond the medium term.  

In the meantime, NMC still has its pedal to the metal and this week announced it had signed off on a $1.6bn joint venture with Saudi Arabia’s state-run Hassana Investment Company to create a network of medical facilities in the kingdom with up to 3,000 beds.

Dividends detonating

NMC has been minded to supercharge the annual dividend in recent years as earnings have swelled by double-digit percentages. So no-one should be surprised that, with City analysts expecting profits to rise an extra 35% this year and 31% in 2019, payouts are anticipated to keep detonating.

Last year’s 13p per share reward is projected to rise to 19.4p in 2018 and again to 25.7p in 2019. These figures yield 0.6% and 0.8% respectively, figures which are admittedly not that impressive. But the pace at which the business could continue to raise dividends over the next decade as its investments pay off should encourage income seekers to take a look.

The current share price weakness at the business leaves it dealing on a sub-1 PEG reading of 0.8. This, in my opinion, reinforces its appeal as one of the most appetising FTSE 100 dividend growth stocks out there.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be considered so you should consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended NMC Health. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

2 simple steps to earning £400 in monthly passive income

Building a monthly passive income stream doesn't have to be complicated, or require a lot of effort. Zaven Boyrazian explains…

Read more »

Female analyst sat at desk looking at pie charts on paper
Investing Articles

Here’s how I’d invest £10,000 for the next FTSE 100 bull market

Is the FTSE 100 heading for a new bull market? After the past decade we've had, investors could do with…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

With a spare £500 I’d buy these UK shares

A financial services giant, a FTSE 250 distributor, a FTSE 100 tech stock, and a gold miner are on the…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Should I buy this defensive FTSE 100 stock for growth and returns?

This Fool takes a closer look at a FTSE 100 stock to see if it could boost his holdings via…

Read more »

Young female analyst working at her desk in the office
Investing Articles

I robbed Mr Market of this cheap FTSE stock!

This FTSE 250 stock has crashed by almost 30% in six months. But I recently bought into this battered business…

Read more »

Mature people enjoying time together during road trip
Investing Articles

3 reasons I’m backing NIO shares to soar!

NIO shares have bounced up and down this year. But where will the share price go next? My bet is…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Up 300%, is the Hurricane Energy share price an opportunity too good to miss?

This Fool looks at why the Hurricane Energy share price has soared in the past 12 months. Should he buy…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

The BT share price crashes 20% in a month. Buy now?

The BT share price has crashed by almost a fifth since coming close to £2 on 12 July. After this…

Read more »